Delivery Order SPE2DB22D2006-SPE2DB25FW3WL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,086.41 to AmerisourceBergen Drug Corp for the supply of Prezcobix 800 mg-150 mg tablets (30-count) on November 5, 2025, with completion expected by November 6, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,617.72, is for the delivery of PREZCOBIX 800 MG-150 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract (SPE2DB22D3016) valued at $11,461.54 to provide 4564249212 PREZCOBIX 800 MG-150 MG TABLET 30S. This delivery order is part of a larger indefinite delivery contract (SPE2DB24FASJ8) awarded solely to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00, which serves as the primary contract vehicle for...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award valued at $66,604.68 from the Defense Logistics Agency's Medical Supply Chain on August 15, 2025. This firm fixed-price contract, which will be completed by August 18, 2025, represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award involves no set-aside designation...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $66,372.00 by the Defense Logistics Agency's Medical Supply Chain on October 13, 2025, with an ultimate completion date of October 14, 2025. This firm fixed-price contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,528.93 by the Defense Logistics Agency's Medical Supply Chain on August 24, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $45,142.44 to AmerisourceBergen Drug Corp on June 6, 2025, with an ultimate completion date of June 9, 2025. This firm fixed-price, non-set-aside contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime contractor, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $15,695.78 by the Defense Logistics Agency's Medical Supply Chain on September 22, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3WLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $67,667.17 to AmerisourceBergen Drug Corp for the supply of Prezcobix 800 mg-150 mg tablets (30-count units) on August 26, 2025, with completion scheduled for August 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. The company's SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. As a prime vendor under this flexible contract framework, AmerisourceBergen Drug Corp serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key supplier within the federal pharmaceutical procurement infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $67.7k | 8/26/25 |